MedTrace Logo

A Trial of Pentoxifylline for the Treatment of Recurrent Aphthous Stomatitis

NCT00315679 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2018-08-03

No results posted yet for this study

Summary

This is a randomized, double blind, placebo controlled trial of the use of pentoxifylline (oxpentifylline) for the treatment of recurrent mouth ulcers.

Conditions

  • Recurrent Aphthous Stomatitis

Interventions

DRUG

Pentoxifylline (also known as oxpentifylline)

Sponsors & Collaborators

  • Manchester University NHS Foundation Trust

    lead OTHER_GOV

Principal Investigators

  • Martin H Thornhill, MBBS, BDS · University of Sheffield School of Clinical Dentistry

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1996-06-30
Primary Completion
1998-11-30
Completion
1998-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00315679 on ClinicalTrials.gov